GLP-3 RT

Retatrutide is a synthetic investigational peptide and triple receptor agonist studied for its activity at three metabolic signaling pathways: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

Its multi-receptor activity has made retatrutide a compound of significant interest in metabolic and endocrine research. Studies have examined its effects on pathways involved in energy balance, glucose and lipid metabolism, appetite signaling, and body-weight regulation.

Product Details:

• Total Content: 5MG or 10MG per vial
• Compound: Retatrutide (GLP-3 RT)
• Compound Form: Lyophilized (freeze-dried) research material supplied in a sealed vial.
• Research Areas: GLP-1, GIP and glucagon receptor signaling; metabolic pathways; energy-balance regulation; and glucose and lipid metabolism research.
• Contents: The stated measurement represents the total retatrutide research material contained within each vial.
• Laboratory Preparation: Additional laboratory materials may be required depending on the applicable research protocol.
• Visual Variations: Vials, caps, and labeling may vary slightly from promotional images.

FOR RESEARCH USE ONLY

Intended strictly for controlled laboratory, analytical, or research purposes. Not for human consumption or medical use.